Page last updated: 2024-08-21

medroxyprogesterone and Endometrial Hyperplasia

medroxyprogesterone has been researched along with Endometrial Hyperplasia in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-199026 (60.47)18.7374
1990's4 (9.30)18.2507
2000's6 (13.95)29.6817
2010's6 (13.95)24.3611
2020's1 (2.33)2.80

Authors

AuthorsStudies
Akbari, H; Boroumand, H; Motedayyen, H; Ostadmohammadi, V; Raygan, F; Tabasi, Z; Tabatabaee Anaraki, S; Vahedpour, Z1
Arnes, M; Lysa, LM; Moe, BT; Orbo, A; Sletten, ET; Straume, B1
Li, J; Luo, B; Luo, L; Sidell, N; Zhang, H; Zheng, Y1
Liu, H; Wang, H; Wang, J; Wang, Y; Zhou, R1
Cao, DY; Cheng, NH; Deng, CY; He, FF; Huang, HF; Shen, K; Sun, ZY; Yang, JX; Yu, M; Yu, Q1
Arnes, M; Orbo, A; Pettersen, I; Straume, B; Vereide, A1
Joo, WD; Ki, KD; Kim, K; Kim, MK; Kim, YH; Lee, TS; Lim, MC; Seong, SJ1
Actis, A; Bergoc, R; Croci, M; Levin, E1
KISTNER, RW1
CRAIG, JM; KISTNER, RW; STEINER, GJ1
Arnes, M; Maltau, JM; Straume, B; Vereide, AB; Ørbo, A1
Arai, T; Jobo, T; Kawaguchi, M; Kuramoto, H1
Kaino, T; Sager, G; Vereide, AB; Ørbo, A1
Chang, WH; Chen, CH; Yu, MH1
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM1
Cleary, RE; Ehrlich, CE; Young, PC1
Studd, JW; Thom, MH1
Jeppsson, S1
Castelo-Branco, C; Durán, M; Fortuny, A; Gratacós, E; Puerto, B; Torné, A; Vanrell, JA1
Citron, JT; Ettinger, B; Ettinger, VM; Hendrickson, MR; Selby, J; Vangessel, A1
Aoki, T; Fukatsu, T; Kaba, S1
Charkviani, L; Charkviani, T; Kobiashvili, H1
Jänne, O; Kauppila, A; Kontula, K; Syrjälä, P; Vihko, R1
Benjamin, I; Block, RE1
de Lima, GR; França, LC; Grabert, H; Miyada, CC; Vivas, AD1
de Koos, EB; Dewhurst, CJ; Haines, RM1
Goyings, LS; Sokolowski, JH1
Haddock, DA1
Hando, T; Kurose, T; Motizuki, M; Ohmori, M; Sasagawa, M; Sasaki, T; Tanaka, K; Yamazaki, T; Yasuda, M1
Ferenczy, A; Gelfand, MM1
Ferenczy, A; Gelfand, M1
Gimes, G; Hidvégi, J; Szarvas, Z; Zsolnai, B1
Allemann, J; Czernobilsky, B; Dallenbach-Hellweg, G1
Griesinger, R; Schindler, AE1
Dallenbach-Hellweg, G1
Contreras Ortiz, O; Sananes, CE1
Labay, GR; Ober, SB1
Zussman, L1
Cox, JE1
Goldzieher, JW; Gorodovsky, J; Maqueo, M; Rice-Wray, E1
Kirsteins, L; Lawrence, AM1
Darragh, A1
Carlos de Souza, J; Coutinho, EM1

Reviews

4 review(s) available for medroxyprogesterone and Endometrial Hyperplasia

ArticleYear
Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    The Cochrane database of systematic reviews, 2018, 12-04, Volume: 12

    Topics: Administration, Oral; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Randomized Controlled Trials as Topic

2018
[Borderline lesions in the endometrium].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Cell Transformation, Neoplastic; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Progesterone Congeners

2004
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
    Der Gynakologe, 1988, Volume: 21, Issue:4

    Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms

1988
Progestagens in bitches: a review.
    The Journal of small animal practice, 1970, Volume: 11, Issue:12

    Topics: Animals; Depression, Chemical; Dog Diseases; Dogs; Endometrial Hyperplasia; Endometritis; Estrus; Female; Medroxyprogesterone; Megestrol; Norethindrone; Pregnancy; Progestins; Pseudopregnancy; Reproduction

1970

Trials

6 trial(s) available for medroxyprogesterone and Endometrial Hyperplasia

ArticleYear
Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    International journal of clinical practice, 2022, Volume: 2022

    Topics: Adult; Dietary Supplements; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Endometrial Hyperplasia; Estradiol; Female; Humans; Iran; Isoflavones; Medroxyprogesterone; Middle Aged

2022
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.
    BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:4

    Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norway; Progestins; Risk; Single-Blind Method; Treatment Outcome

2014
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.
    Gynecologic oncology, 2003, Volume: 91, Issue:3

    Topics: Adult; Cell Nucleus; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged

2003
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Gynecologic oncology, 2005, Volume: 97, Issue:3

    Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2

2005
Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
    Maturitas, 1994, Volume: 19, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Biopsy; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Monitoring, Physiologic; Ultrasonography

1994
A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
    Obstetrics and gynecology, 1989, Volume: 74, Issue:3 Pt 1

    Topics: Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Prospective Studies; Random Allocation; Uterine Hemorrhage; Uterine Neoplasms

1989

Other Studies

33 other study(ies) available for medroxyprogesterone and Endometrial Hyperplasia

ArticleYear
Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.
    Anticancer research, 2017, Volume: 37, Issue:5

    Topics: Administration, Oral; Adult; Aged; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Receptors, Progesterone; Recurrence

2017
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019, Volume: 29, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome

2019
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Zhonghua fu chan ke za zhi, 2013, Volume: 48, Issue:7

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Young Adult

2013
Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
    Japanese journal of clinical oncology, 2015, Volume: 45, Issue:10

    Topics: Adult; Biopsy, Fine-Needle; Contraceptive Agents, Female; Curettage; Endometrial Hyperplasia; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Prospective Studies; Republic of Korea

2015
8-Chloro-cAMP-related changes on mice uteri.
    TheScientificWorldJournal, 2002, May-22, Volume: 2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Endometrial Hyperplasia; Endometrium; Estrus; Female; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Organ Size; Pregnancy; Pseudopregnancy; Tamoxifen; Uterus

2002
STEROID COMPOUNDS WITH PROGESTATIONAL ACTIVITY.
    Postgraduate medicine, 1964, Volume: 35

    Topics: Contraception; Dysmenorrhea; Endometrial Hyperplasia; Endometriosis; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Menorrhagia; Norethindrone; Norethynodrel; Pregnancy; Progestins; Uterine Neoplasms

1964
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
    Metabolism: clinical and experimental, 1963, Volume: 14

    Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms

1963
Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2006, Volume: 92, Issue:2

    Topics: Adenocarcinoma; Adult; Contraceptives, Oral, Synthetic; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Infertility, Female; Medroxyprogesterone; Treatment Outcome

2006
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
    Obstetrics and gynecology, 1980, Volume: 55, Issue:6

    Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms

1980
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    American journal of obstetrics and gynecology, 1981, Nov-01, Volume: 141, Issue:5

    Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms

1981
Procedures in practice. Hormone implantation.
    British medical journal, 1980, Mar-22, Volume: 280, Issue:6217

    Topics: Climacteric; Delayed-Action Preparations; Endometrial Hyperplasia; Estradiol; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone; Norethindrone; Testosterone; Uterine Hemorrhage

1980
Background, development and properties of progestagens, with special reference to medroxyprogesterone acetate (MPA).
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1981, Volume: 101

    Topics: Animals; Contraceptives, Oral, Synthetic; Endometrial Hyperplasia; Endometrium; Estrus; Female; Humans; Medroxyprogesterone; Menstruation; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rabbits

1981
Cyclic hormone replacement therapy using quarterly progestin.
    Obstetrics and gynecology, 1994, Volume: 83, Issue:5 Pt 1

    Topics: Adult; Drug Administration Schedule; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Menstruation; Middle Aged; Patient Satisfaction; Postmenopause; Time Factors; Ultrasonography; Uterine Hemorrhage

1994
Endometrial cytology in postmenopausal hormone replacement therapy.
    Diagnostic cytopathology, 1998, Volume: 19, Issue:3

    Topics: Adult; Aged; Cell Nucleus; Cytodiagnosis; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone

1998
Organ preserving method in the management of atypical endometrial hyperplasia.
    European journal of gynaecological oncology, 2001, Volume: 22, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Endometrial Hyperplasia; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy; Progesterone Congeners

2001
Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
    International journal of cancer, 1979, Nov-15, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Adult; Cytosol; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Progesterone; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms

1979
Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
    Obstetrics and gynecology, 1977, Volume: 50, Issue:2

    Topics: Adolescent; Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Progesterone; Turner Syndrome; Uterine Neoplasms

1977
[Endometrial adenomatous hyperplasia. Analysis of the karyometric variations caused by medorxyprogesterone acetate].
    AMB : revista da Associacao Medica Brasileira, 1976, Volume: 22, Issue:5

    Topics: Adenoma; Adult; Aged; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Epithelium; Female; Humans; Karyometry; Medroxyprogesterone; Menopause; Menstruation; Middle Aged

1976
Replacement hormone therapy in gonadal dysgenesis.
    British journal of obstetrics and gynaecology, 1975, Volume: 82, Issue:5

    Topics: Adolescent; Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Megestrol; Norethindrone; Polyps; Progestins; Turner Syndrome; Uterine Neoplasms

1975
Histologic evaluation of gallbladder in progestogen-treated bitches.
    American journal of veterinary research, 1975, Volume: 36, Issue:08

    Topics: Animals; Dog Diseases; Dogs; Endometrial Hyperplasia; Female; Gallbladder; Medroxyprogesterone; Mucous Membrane

1975
A simple way to manage menopause.
    Postgraduate medicine, 1990, Sep-01, Volume: 88, Issue:3

    Topics: Aged; Calcitonin; Calcium; Climacteric; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Physical Exertion; Risk Factors

1990
[Diagnosis and treatment of endometrial hyperplasia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-3

    Topics: ABO Blood-Group System; Adenocarcinoma; DNA Polymerase II; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oncogenes; Protein Biosynthesis; Receptors, Estrogen; Uterine Neoplasms

1989
The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.
    American journal of obstetrics and gynecology, 1989, Volume: 160, Issue:1

    Topics: Adenocarcinoma; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Middle Aged; Prospective Studies; Recurrence; Uterine Neoplasms

1989
[Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
    Morphologiai es igazsagugyi orvosi szemle, 1985, Volume: 25, Issue:4

    Topics: Aged; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Preoperative Care; Uterine Neoplasms

1985
[Medroxyprogesterone acetate in adenomatous hyperplasia of the uterine endometrium. Clinical and morphologic studies on the duration and dosage of gestagen therapy].
    Geburtshilfe und Frauenheilkunde, 1986, Volume: 46, Issue:9

    Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged

1986
[Therapy with gestagens in hyperplastic changes of the endometrium].
    Geburtshilfe und Frauenheilkunde, 1986, Volume: 46, Issue:10

    Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms

1986
Hormonal receptors in endometrial neoplasias.
    European journal of gynaecological oncology, 1988, Volume: 9, Issue:5

    Topics: Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms

1988
The histopathology of the endometrium: selected topics.
    Obstetrics and gynecology annual, 1972, Volume: 1

    Topics: Adenocarcinoma; Biopsy; Chlormadinone Acetate; Contraceptives, Oral; Endometrial Hyperplasia; Endometritis; Endometrium; Estradiol; Estrogens; Female; Histocytochemistry; Humans; Intrauterine Devices; Medroxyprogesterone; Menstruation; Mestranol; Microscopy, Electron; Norethynodrel; Norgestrel; Ovulation; Time Factors; Uterine Neoplasms

1972
The climacteric.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone

1973
Endometrial regeneration in patients discontinuing oral contraceptives.
    Fertility and sterility, 1970, Volume: 21, Issue:3

    Topics: Adult; Amenorrhea; Biopsy; Contraceptives, Oral; Endometrial Hyperplasia; Endometrium; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Regeneration

1970
Progestins in the medical management of active acromegaly.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:5

    Topics: Acromegaly; Arginine; Carcinoma; Depression, Chemical; Endometrial Hyperplasia; Estrogens; Female; Feminization; Glucose Tolerance Test; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Immunoassay; Medroxyprogesterone; Metrorrhagia; Thromboembolism

1970
Indications for therapy with progestational agents.
    Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 1970, Volume: 25, Issue:4-6

    Topics: Breast Diseases; Contraceptives, Oral; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Ethisterone; Ethynodiol Diacetate; Female; Humans; Male; Medroxyprogesterone; Menstruation Disturbances; Mental Disorders; Migraine Disorders; Norethindrone; Progesterone; Progestins; Sexual Dysfunction, Physiological

1970
Conception control by monthly injections of medroxyprogesterone suspension and long-acting oestrogen.
    Journal of reproduction and fertility, 1968, Volume: 15, Issue:2

    Topics: Contraceptive Agents; Delayed-Action Preparations; Endometrial Hyperplasia; Estradiol; Female; Humans; Infertility, Female; Medroxyprogesterone; Menstruation

1968